Markus Morkel
Anna Louise Karsch Str. 2
Berlin, BE 10178, Germany
Berlin, BE 10178, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Pooled single-cell screen in colorectal cancer defines transcriptional modules linked to oncogenes.
Journal: Molecular systems biology
Published: August 19, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancer.
Journal: Science signaling
Published: July 22, 2025
Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cells.
Journal: Stem cell research & therapy
Published: June 20, 2025
High-confidence calling of normal epithelial cells allows identification of a novel stem-like cell state in the colorectal cancer microenvironment.
Journal: International journal of cancer
Published: February 28, 2024
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissue.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 23, 2024
Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling.
Journal: Med (New York, N.Y.)
Published: October 10, 2023
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Journal: British journal of cancer
Published: December 04, 2022
Oncogenic signaling is coupled to colorectal cancer cell differentiation state.
Journal: The Journal of cell biology
Published: April 01, 2022
The single-cell transcriptional landscape of lung carcinoid tumors.
Journal: International journal of cancer
Published: December 23, 2021
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
Journal: PLoS biology
Published: November 11, 2021
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: October 06, 2021
Last Updated: 09/26/2026